Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine for Prevention of Thienopyridine-related Peptic Ulcer
NCT02418312Completed
- Sponsor
- Kaohsiung Veterans General Hospital
- Start
- Jan 2012
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in peptic ulcer disease (PUD) comparing Famotidine Group with Placebo Group (2 arms). Primary endpoint: Number of Participants With Healed Peptic Ulcer at 6 months. Started Jan 2012; status: completed.
02
Drugs
famotidine
03
Conditions
peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT02418312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02418312.